Burcon Receives Notice of Allowance From the United States Patent Office for
VANCOUVER, British Columbia, Feb. 26, 2013 (GLOBE NEWSWIRE) -- Burcon
NutraScience Corporation (TSX:BU) (Nasdaq:BUR) ("Burcon") is pleased to
announce today that it has received a notice of allowance from the United
States Patent and Trademark Office for apatent application covering a process
for the production of CLARISOY™ soy protein. A notice ofallowance from the
United States Patent and Trademark Office is a written notification thata
patent application has cleared internal review and is pending issuance.
"This is a significant development for Burcon as it marks the first of our
CLARISOY™ patents to be allowed in the United States.CLARISOY™ soy protein's
distinct characteristics make it uniquely soluble, great tasting and with an
excellent nutritional value," said Johann F. Tergesen, President and Chief
Operating Officer,adding, "Our processes for the production of highly
functional and nutritional plant-based proteins make them especially useful
for those food and beverage applications that are in high demand today,
namely: health & wellness products."
To-date, Burcon's patent portfolio consists of 218 issued patents in various
countries,including 36 issued U.S. patents, and in excess of 400 additional
pending patent applications,81 of which are U.S. patent applications. The
patent allowance which is the subject of this news release will be issued as a
granted U.S. patent in the near future.
The CLARISOY™ Advantage
CLARISOY™, which is under license to ADM, is the world's only vegetable-based
protein capable of offering both clarity and high-quality protein nutrition in
low pH beverage systems.
In March 2011, Burcon entered into a License and Production Agreement with ADM
(the "License Agreement") for the worldwide production, distribution and sale
of CLARISOY™soy protein.The License Agreement gives ADM exclusive rights
across all geographic regions and all potential product applications to
produce, market, and sell CLARISOY™ soy protein.ADM makes royalty payments to
Burcon on the sales of CLARISOY™ under the license agreement.
ADM's CLARISOY™ line includes a range of products for both low and neutral pH
applications allowing food and beverage companies to easily include up to 10
grams of CLARISOY™ per serving.
CLARISOY™ 100 is a premier vegetable-based protein that offers both clarity
and high-quality protein nutrition for beverages with a pH of less than 4.
Extremely heat stable, CLARISOY™ 100 requires no homogenization or stabilizers
in low pH beverages.
CLARISOY™ 150 is a revolutionary soy protein for neutral pH beverages and low
pH beverages with cloud systems.The clean flavor and smooth mouth-feel makes
CLARISOY™ 150 a formulator's ideal protein ingredient.
For more information about CLARISOY™, visitwww.clarisoy.com
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We have developed
CLARISOY™ soy protein, which offers clarity and high-quality protein nutrition
for low pH beverage systems; Peazazz™ a uniquely soluble and clean-tasting pea
protein and Puratein®, Supertein™ and Nutratein™ canola protein isolates with
unique functional and nutritional attributes. Our team of highly specialized
scientists and engineers work from our private research facility to develop
and optimize environmentally sound technologies. To-date, our patent portfolio
consists of 218 issued patents in various countries, including 36 issued U.S.
patents, and in excess of 400 additional pending patent applications, 81 of
which are U.S. patent applications.
CLARISOY™ is under license from Archer Daniels Midland Company.
CLARISOY™ is a trademark of Archer Daniels Midland Company.
ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the adequacy
of the content of the information contained herein. This press release
contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results, performances,
prospects and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other than
statements of historical fact included in this release are forward-looking
statements, including, without limitation, statements regarding plans and
timing for the introduction or enhancement of our products, statements about
future market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release. There can
be no assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those anticipated in
such statements or information. Important factors that could cause actual
results to differ materially from Burcon's plans and expectations include the
actual results of marketing activities, adverse general economic, market or
business conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with securities
regulators and stock exchanges, including in the section entitled "Risk
Factors" in Burcon's annual information form dated June 25, 2012.Any
forward-looking statement or information only speaks as of the date on which
it was made and, except as may be required by applicable securities laws,
Burcon disclaims any intent or obligation to update any forward-looking
statement, whether as a result of new information, future events or otherwise.
Although Burcon believes that the assumptions inherent in the forward-looking
statements are reasonable, forward-looking statements are not guarantees of
future performance and accordingly undue reliance should not be put on such.
CONTACT: Michael Kirwan, Director, Corporate Development
Burcon NutraScience Corporation
(604) 733-0896 / (888) 408-7960 toll-free
Press spacebar to pause and continue. Press esc to stop.